The development of interferon-based gene therapy for BCG unresponsive bladder cancer: from bench to bedside

ConclusionsOver the past two decades, gene therapy has evolved into a powerful tool in our fight against cancer. After overcoming the initial barriers associated with gene delivery to the bladder, we have made significant strides forward in developing this novel therapeutic strategy for the treatment of this inherently resistant disease state. Our results to date are very encouraging; however, much work lies ahead to better understand and optimize this novel approach for treating non-muscle invasive bladder.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research